NYLI MacKay Short Duration High Inc Cl I MDHIX Fund Analysis

| Medalist Rating as of | See New York Life Investment Hub

Morningstar’s Analysis MDHIX

Will MDHIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong team following a consistent approach.

Analyst Jeana Marie Doubell

Jeana Marie Doubell

Analyst

Summary

MainStay MacKay Short Duration High Income (previously named MacKay Shields Short Duration High Yield) boasts an experienced team and a sound process, though its short-duration focus limits potential relative to wider-ranging peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Sponsor Center